Veterinary Medicine Information website

Dexafort, 3 mg/ml süstesuspensioon veistele, hobustele, koertele ja kassidele

Not authorised
  • Dexamethasone sodium phosphate
  • DEXAMETHASONE 21-PHENYLPROPIONATE
Download as PDF

Product identification

Medicine name:
Dexafort, 3 mg/ml süstesuspensioon veistele, hobustele, koertele ja kassidele
Active substance:
  • Dexamethasone sodium phosphate
  • DEXAMETHASONE 21-PHENYLPROPIONATE
Target species:
  • Horse
  • Cattle
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Dexamethasone sodium phosphate
    1.32
    milligram(s)
    /
    1.00
    millilitre(s)
  • DEXAMETHASONE 21-PHENYLPROPIONATE
    2.67
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        47
        day
      • Milk
        no withdrawal period
    • Cattle
      • Meat and offal
        53
        day
      • Milk
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vet Pharma Friesoythe GmbH
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1186
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 19/06/2023
Download